Quadrivalent HPV recombinant vaccine

HPV vaccine · Shanghai Bovax Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Quadrivalent HPV recombinant vaccine, covering 2023-07-21 to 2023-07-21. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females [Phase 3]

See pricing